shortages of medicinal products<\/a>.<\/p>\nThe circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures. These are:<\/p>\n
[\/et_pb_text][et_pb_blurb image=”https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/05\/number-one.png” _builder_version=”4.22.2″ _module_preset=”default” theme_builder_area=”post_content” alt=”number one” title_text=”number one” icon_placement=”left” body_font_size=”1.2em” body_line_height=”1.3em” content_max_width=”100%” hover_enabled=”0″ sticky_enabled=”0″]Marketing authorization for products included in the official list of vital and unavailable medicines.[\/et_pb_blurb][et_pb_blurb image=”https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/05\/number-two.png” _builder_version=”4.22.2″ _module_preset=”default” theme_builder_area=”post_content” alt=”number two” title_text=”number two” icon_placement=”left” body_font_size=”1.2em” body_line_height=”1.3em” content_max_width=”100%” hover_enabled=”0″ sticky_enabled=”0″]Medicines officially declared to be “in short supply or at risk of shortage”.[\/et_pb_blurb][et_pb_blurb image=”https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/05\/number-three.png” _builder_version=”4.22.2″ _module_preset=”default” theme_builder_area=”post_content” alt=”number three” title_text=”number three” icon_placement=”left” body_font_size=”1.2em” body_line_height=”1.3em” content_max_width=”100%” hover_enabled=”0″ sticky_enabled=”0″]Strategic products for public health.[\/et_pb_blurb][et_pb_blurb image=”https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/05\/number-four.png” _builder_version=”4.22.2″ _module_preset=”default” theme_builder_area=”post_content” alt=”number four” title_text=”number four” icon_placement=”left” body_font_size=”1.2em” body_line_height=”1.3em” content_max_width=”100%” hover_enabled=”0″ sticky_enabled=”0″]Amendments to one or more marketing authorizations that may be necessary to prevent or reduce the risk of a shortage of medicinal products.[\/et_pb_blurb][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” theme_builder_area=”post_content” text_font_size=”1.2em” text_line_height=”1.5em” hover_enabled=”0″ sticky_enabled=”0″]Applicants with procedures falling under some of the above cases may request that these pending procedures be assessed according to the provisions of the new Circular. <\/p>\n
It is not clear whether procedures prioritized under the previous circular\u202f(Circular 40), but falling outside the specified cases, will retain their prioritization. <\/p>\n
In principle, this is a preventive measure that arose because of the drug shortage alerts that were issued in the country at the beginning of October. It is still pending for INVIMA to define how it will be applied. <\/p>\n
Original source in Spanish. [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
On October 25, INVIMA issued Circular DG-1000-0012-2023, which replaces Circular DG1000-040-2018 on risk management of potential shortages of medicinal products. The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures. These are:Marketing authorization for products included in the official list of vital and unavailable medicines.Medicines officially declared to be “in short supply or at risk of shortage”.Strategic products for public health.Amendments to one or more marketing authorizations that may be necessary to prevent or reduce the risk of a shortage of medicinal products.Applicants with procedures falling under some of the above cases may request that these pending procedures be assessed according to the provisions of the new Circular. It is not clear whether procedures prioritized under the previous circular\u202f(Circular 40), but falling outside the specified cases, will retain their prioritization. In principle, this is a preventive measure that arose because of the drug shortage alerts that were issued in the country at the beginning of October. It is still pending for INVIMA to define how it will be applied. Original source in Spanish.<\/p>\n","protected":false},"author":5,"featured_media":4400127,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[59,109],"tags":[],"yoast_head":"\n
Preventive measures must be taken to avoid medication shortages - OlarteMoure | Intellectual Property<\/title>\n<meta name=\"description\" content=\"The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Preventive measures must be taken to avoid medication shortages\" \/>\n<meta property=\"og:description\" content=\"The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-03T17:48:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-03T17:48:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1601\" \/>\n\t<meta property=\"og:image:height\" content=\"837\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicole Diaz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicole Diaz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/\",\"url\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/\",\"name\":\"Preventive measures must be taken to avoid medication shortages - OlarteMoure | Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\/\/www.olartemoure.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg\",\"datePublished\":\"2023-11-03T17:48:12+00:00\",\"dateModified\":\"2023-11-03T17:48:23+00:00\",\"author\":{\"@id\":\"https:\/\/www.olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31\"},\"description\":\"The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#primaryimage\",\"url\":\"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg\",\"contentUrl\":\"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg\",\"width\":1601,\"height\":837,\"caption\":\"changes in invima\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.olartemoure.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Preventive measures must be taken to avoid medication shortages\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.olartemoure.com\/#website\",\"url\":\"https:\/\/www.olartemoure.com\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.olartemoure.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31\",\"name\":\"Nicole Diaz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.olartemoure.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d137136e1adced7f50db0a1fb56c2345?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d137136e1adced7f50db0a1fb56c2345?s=96&d=mm&r=g\",\"caption\":\"Nicole Diaz\"},\"sameAs\":[\"https:\/\/www.olartemoure.com\"],\"url\":\"https:\/\/www.olartemoure.com\/en\/author\/webmaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Preventive measures must be taken to avoid medication shortages - OlarteMoure | Intellectual Property","description":"The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/","og_locale":"en_US","og_type":"article","og_title":"Preventive measures must be taken to avoid medication shortages","og_description":"The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures.","og_url":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2023-11-03T17:48:12+00:00","article_modified_time":"2023-11-03T17:48:23+00:00","og_image":[{"width":1601,"height":837,"url":"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg","type":"image\/jpeg"}],"author":"Nicole Diaz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicole Diaz","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/","url":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/","name":"Preventive measures must be taken to avoid medication shortages - OlarteMoure | Intellectual Property","isPartOf":{"@id":"https:\/\/www.olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#primaryimage"},"image":{"@id":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#primaryimage"},"thumbnailUrl":"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg","datePublished":"2023-11-03T17:48:12+00:00","dateModified":"2023-11-03T17:48:23+00:00","author":{"@id":"https:\/\/www.olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31"},"description":"The circular specifies certain cases in which preventive measures must be taken to avoid shortages, including the prioritization of certain regulatory procedures.","breadcrumb":{"@id":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#primaryimage","url":"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg","contentUrl":"https:\/\/www.olartemoure.com\/wp-content\/uploads\/2023\/11\/changes-in-invima.jpg","width":1601,"height":837,"caption":"changes in invima"},{"@type":"BreadcrumbList","@id":"https:\/\/www.olartemoure.com\/en\/preventive-measures-medication-shortages\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"Preventive measures must be taken to avoid medication shortages"}]},{"@type":"WebSite","@id":"https:\/\/www.olartemoure.com\/#website","url":"https:\/\/www.olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.olartemoure.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31","name":"Nicole Diaz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.olartemoure.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d137136e1adced7f50db0a1fb56c2345?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d137136e1adced7f50db0a1fb56c2345?s=96&d=mm&r=g","caption":"Nicole Diaz"},"sameAs":["https:\/\/www.olartemoure.com"],"url":"https:\/\/www.olartemoure.com\/en\/author\/webmaster\/"}]}},"_links":{"self":[{"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/4400126"}],"collection":[{"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=4400126"}],"version-history":[{"count":0,"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/4400126\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/media\/4400127"}],"wp:attachment":[{"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=4400126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=4400126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=4400126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}